University, Astellas Fight To Keep Prostate Cancer Patent
The University of California's governing board clashed with three generic-drug makers trying to revoke the institution's patent for a prostate cancer drug in a London court Monday, arguing that the institution's...To view the full article, register now.
Already a subscriber? Click here to view full article